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Blood pressure (BP) has been reported to be directly related to mortality from vascular disease down to at least 115/75 
mm Hg with no clear threshold level.1 Evidence from previ-
ous research suggests that low BP is a predictor of mortality 
in various clinical settings, and J- or U-curve associations 
between BP and vascular mortality have been reported among 
the elderly and those with vascular or other diseases.2–9 Low 
BP, even a single incidence of isolated hypotensive BP in cer-
tain situations, can predict mortality,10 but despite the evidence, 
physicians often ignore low BP.10,11 There is no doubt, however, 
that a J-curve association between BP and mortality exists, even 
in the general population with no known comorbid diseases, 
because adequate perfusion to vital organs is difficult to sustain 
below a certain BP. In nonclinical populations, a few studies 
have found that low BP was associated with a higher mortality 
from vascular disease.12–14 However, it is unclear whether and 
in what range of BP a J-curve occurs. We conducted a large 
prospective cohort study with >1 million participants to dem-
onstrate whether a J-curve association exists between systolic 
BP (SBP) and mortality from vascular disease in a nonclinical 
population. We focused on SBP, because SBP has been shown 
to be a better predictor of mortality from vascular disease than 
diastolic BP (DBP) or pulse pressure in prospective studies 
among the general population.1,15,16
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Methods
Study Participants
The Korean Cancer Prevention Study comprises 1 329 525 individuals 
(482 618 women) aged 30 to 95 years who underwent at least 1 routine 
medical examination by the Korean Medical Insurance Corporation 
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(a former branch of the National Health Insurance Service) between 
1992 and 1995.17–19 For participants who underwent ≥2 examinations, 
data from the first examination were used. Approximately 96% of 
South Koreans are covered by the National Health Insurance Service, 
through which all Korean citizens are eligible to participate in regu-
lar health examinations. Six hundred ninety-six individuals who died 
during the year of enrollment were dropped from the sample. Other 
participants that were excluded consisted of 43 411 individuals whose 
records were missing information on body mass index (BMI), alcohol 
intake, blood pressure, fasting blood glucose levels, or total choles-
terol levels; 49 483 persons who self-reported having cancer, liver dis-
ease, cardiovascular diseases (hypertension, heart disease, or stroke), 
or a respiratory disease at or before the baseline survey; and 689 per-
sons with an extremely low BMI (<15.0 kg/m2) or an extremely short 
stature (≤1.3 m). Thus, 1 235 246 individuals (445 239 women) were 
finally included in the study. The institutional review boards of Yonsei 
University and the Johns Hopkins University Bloomberg School of 
Public Health approved the study.
Data Collection
All participants underwent medical examinations at local hospitals. 
A standard mercury sphygmomanometer was used to measure BP in 
a seated position, and the SBP and DBP were measured as the first 
and fifth Korotkoff sounds, respectively. Total cholesterol and glu-
cose levels were assayed from a fasting serum specimen, and each 
participating hospital in the examination had external quality con-
trol procedures that were supervised by the Korean Association of 
Laboratory Quality Control. The status of cigarette smoking (never, 
former, current), alcohol intake (grams of ethanol per day), and cur-
rent participation in physical exercise (yes or no) were also collected 
by using self-reported questionnaires. Height and weight were mea-
sured while the participants wore light clothing without shoes, and 
BMI was calculated as weight in kilograms divided by height in 
meters squared (kg/m2).
Follow-Up and Outcomes
Mortality of participants from 1993 through December 31, 2012 was 
confirmed with death records from the National Statistical Office of 
Korea.20 The follow-up was performed through record linkage at the 
national level and was complete. The main outcomes for this study 
were death from atherosclerotic vascular diseases (I10–I15 [hyper-
tensive diseases], I20–I25, I44–I52, I60–I69, I70–I74 [diseases of 
arteries], R96 [other sudden death with cause unknown]), ischemic 
heart diseases (I20–I25), total stroke (I60–I69), hemorrhagic stroke 
(I60–I62), and ischemic stroke (I63), as defined by the International 
Classification of Diseases, Tenth Revision. More details of the dis-
eases for each International Classification of Diseases, Tenth Revision 
code are presented in Table I in the online-only Data Supplement.
Statistical Analysis
SBP was classified into 8 groups (mm Hg <90 [range, 60–89], 90–99 
[reference group], 100–109, 110–119, 120–139, 140–159, 160–179, 
and ≥180 [range, 180–290]). The SBP category with the lowest vas-
cular risk was used as the referent group. χ2 tests and 1-way analysis 
of variance were performed to compare the differences between SBP 
groups.
Cox proportional hazards models were used to evaluate the asso-
ciation between SBP at baseline and mortality, and the analyses were 
adjusted for the following covariates: age at entry (continuous); sex; 
smoking status (never, former, current smoker); alcohol intake (g/d; 
0, 1–20, >20); physical activity (yes, no); total cholesterol (mg/dL; 
continuous); fasting serum glucose (mg/dL; continuous), and BMI 
(kg/m2; continuous). The HRs of restricted cubic spline transforma-
tion of continuous confounders with 3 knots (5th, 50th, and 95th 
percentiles) with death from atherosclerotic vascular disease were 
plotted (Figure I in the online-only Data Supplement). DBP was 
adjusted for as a continuous variable by using restricted cubic splines 
with 5 knots (50, 60, 70, 80, and 90 mm Hg) to examine whether the 
effects of SBP are independent of those of DBP. HRs of restricted 
cubic spline transformation of SBP with 5 knots (80, 90, 100, 110, 
and 120 mm Hg) and 90 mm Hg as a reference were also plotted. The 
nonlinear associations of SBP with vascular mortality were assessed 
with a likelihood ratio test, in which we compared the model with 
only the linear term with the model with both the linear and the cubic 
spline terms.
A stratified analysis was performed according to age at entry 
(≥60 or <60 years) to examine whether association varied accord-
ing to age group.1,13,21 Sex-stratified analysis was also done. In addi-
tional analyses, we excluded all deaths (n=23 372) that had occurred 
in the first 5 years of follow-up.12 These analyses ensured sensitivity 
in our results. The interaction of age or sex with SBP on mortality 
was assessed by including an interaction term (age × SBP or sex × 
SBP) in the analysis stratified by SBP (<100 or ≥100 mm Hg), assum-
ing a linear inverse association at <100 mm Hg and a linear positive 
association at ≥100 mm Hg. Proportional assumption was tested by 
using Schoenfeld residuals. The survival curve according to SBP was 
plotted using the life-table method (Figure II in the online-only Data 
Supplement).
Two-sided P values were calculated, and the statistical signifi-
cance level was set at 0.05. All statistical analyses were performed 
using SAS version 9.2 (SAS Institute, Cary, NC).
Results
A total of 154 882 deaths (crude death rate, 683 deaths per 
100 000 person-years) occurred during 22 674 299 person-
years (mean, 18.4 person-years) of follow-up, and of these, 
34 816 died of atherosclerotic vascular diseases (154 deaths 
per 100 000 person-years). At enrollment, the mean (stan-
dard deviation) age was 46.6 (11.6) years, and the mean SBP 
was 123.4 (17.2) mm Hg (Table 1). Participants with SBP 
<90 mm Hg tended to be women and had the lowest levels of 
DBP, total cholesterol, fasting glucose, and BMI of all SBP 
groups. They were also older than those with SBPs of 90 to 
139 mm Hg (Table II in the online-only Data Supplement). 
The proportion of current smokers and current drinkers was 
highest in individuals with SBPs of 120 to 139 mm Hg.
Both low and high SBPs were associated with higher ath-
erosclerotic vascular mortality (Figures 1 and 2), and the low-
est atherosclerotic vascular mortality was associated with an 
SBP of 90 to 109 mm Hg, which rose thereafter as the SBP 
increased; the mortality was also higher in those with an SBP 
<90 mm Hg (hazard ratio [HR], 1.53; 95% confidence inter-
val [CI], 1.15–2.03; Table 2). The HR associated with an SBP 
below 90 mm Hg, in comparison with 90 to 99 mm Hg, was 
2.54 (95% CI, 1.51–4.29) for ischemic heart disease, and 1.21 
(95% CI, 0.79–1.86) for stroke. Among stroke subtypes, the 
HR associated with an SBP <90 mm Hg was 1.64 for hemor-
rhagic stroke mortality and 0.76 for ischemic stroke mortality.
After exclusion of the first 5 years of follow-up, the associ-
ation between the lowest SBP group and vascular mortality did 
not weaken (Figure III in the online-only Data Supplement). 
When DBP (restricted cubic splines with 5 knots at 50, 60, 
70, 80, and 90 mm Hg), and restricted cubic splines of con-
tinuous confounders (age, total cholesterol, BMI, and fasting 
glucose) with 3 knots at the 5th, 50th, and 95th percentile of 
each variable were added, the observed associations with low 
SBP were generally unchanged (Figure IV in the online-only 
Data Supplement).
When stratified by age group, higher HRs associated 
with the lowest SBP for atherosclerotic vascular mortality 
and ischemic heart disease in comparison with the reference 
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were statistically significant in older participants aged 60 
to 95 years, but not in younger participants aged 30 to 59 
years (Figure 3, Figures V and VI in the online-only Data 
Supplement, Table III in the online-only Data Supplement). 
In addition, in stratified analyses by SBP assuming linear 
associations (Tables IV through VI in the online-only Data 
Supplement), in the range <100 mm Hg, HR of atheroscle-
rotic vascular mortality for each 10 mm Hg increase in SBP 
was 0.65 (95% CI, 0.50–0.84) and 0.89 (95% CI, 0.53–1.49), 
respectively, in participants aged 60 to 95 years versus those 
aged 30 to 59 years (Figure 4, Table V in the online-only Data 
Supplement). However, when interactions between age and 
SBP were evaluated by using interaction terms of age and 
SBP, the P value was >0.05 for each type of vascular mortality 
given an SBP <100 mm Hg. In individuals aged 60 to 95 years, 
and in those aged 30 to 59 years, as well, vascular mortality 
increased as SBP increased to >90 to 99 mm Hg, and the asso-
ciation between high SBP and vascular mortality was greater 
among individuals <60 years than it was among those aged 60 
to 95 years. The P values for the linear interaction between 
age and SBP were <0.001 for vascular mortality given an SBP 
of 100 to 290 mm Hg.
In analyses stratified by sex, the HRs associated with the 
lowest SBP for atherosclerotic vascular diseases were 1.63 
(95% CI, 1.13–2.34) in women and 1.37 (95% CI, 0.87–2.14) 
in men (Figures VII through IX in the online-only Data 
Supplement, Table VII in the online-only Data Supplement). 
However, P values of linear interaction between men and 
women in the range <100 mm Hg were generally >0.05 (Table 
VI in the online-only Data Supplement).
We tested the proportional assumption and found no evi-
dence of a violation of the proportional assumption for the 
dummy variable of SBP <90 mm Hg for any cause of vascular 
mortality. However, evidence indicated that several variables 
including several dummy SBP variables may have nonpropor-
tional HRs over the follow-up time period. For such variables, 
analysis was done by stratifying according to the variables (not 
dummy SBP variables such as alcohol consumption and exer-
cise). In addition, time-dependent covariables for dummy SBP 
variables (which were generated using the Model Statement of 
the PROC PHREG procedure) were included to address non-
proportionality.22 In addition, we analyzed individuals who sur-
vived as of January 1, 2003 to examine whether the association 
of SBP in 2003 to 2012 was different from that during the entire 
follow-up period (1993–2012). The associations with low SBP 
were unchanged (Figure X in the online-only Data Supplement).
Discussion
Investigation of a healthy Korean population without known 
preexisting illnesses exhibited J-curve associations between 
SBP and death from atherosclerotic vascular diseases, with 
a nadir at 90 to 109 mm Hg for vascular mortality. An SBP 
<90 mm Hg was associated with ≈50% higher mortality from 
atherosclerotic vascular disease, especially ischemic heart dis-
ease (≈150% higher mortality), in comparison with an SBP of 
90 to 99 mm Hg.
Association Between Low SBP and Vascular 
Mortality
This study revealed that SBPs <90 mm Hg are related to an 
increased risk of vascular mortality. The majority of previous 
reports on the J-curve association between BP and vascular 
mortality studied clinical patients with vascular disease,2–6,9,23 
and, although similar findings have been reported in Korean 
nonclinical populations, those results are limited by a small 
number of deaths in the lowest SBP categories and the self-
reported nature of BP measurements.13,14 The current study 
clearly showed that J-curve associations exist between SBP 
and vascular mortality, especially mortality from ischemic 
heart disease, in Korean adults.
Table 1. Baseline Characteristics of Participants
Variables n (%)
Person-years, person-year (%) 22 674 299 (100.0)
Age, mean (SD), y 46.6 (11.6)
SBP, mean (SD), mm Hg 123.4 (17.2)
DBP, mean (SD), mm Hg 80.0 (11.7)
BMI, mean (SD), kg/m2 23.2 (2.8)
Total cholesterol,* mean (SD), mg/dL 192.4 (38.4)
Fasting glucose,† mean (SD), mg/dL 92.0 (24.7)
Sex
  Women 445 239 (36.0)
  Men 790 007 (64.0)
Exercise
  No 934 474 (75.7)
  Yes 300 772 (24.5)
Smoking
  Current smoker 483 708 (39.2)
  Never smoker 581 615 (47.1)
  Past smoker 169 923 (13.8)
Drinking, g ethanol/d
  0 565 743 (45.8)
  1–19 440 644 (35.7)
  ≥20 228 859 (18.5)
SBP, mm Hg‡
  <90 1862 (0.2)
  90–99 21 414 (1.7)
  100–109 107 283 (8.7)
  110–119 283 313 (22.9)
  120–139 573 091 (46.4)
  140–159 186 067 (15.1)
  160–179 47 204 (3.8)
  ≥180 15 012 (1.2)
BMI indicates body mass index; DBP, diastolic blood pressure; SBP, systolic 
blood pressure; and SD, standard deviation.
*To convert glucose from mg/dL to mmol/L, multiply by 0.0555.
†To convert cholesterol from mg/dL to mmol/L, multiply by 0.0259.
‡The range of the lowest and highest SBP groups was 60–89 mm Hg and 
180–290 mm Hg, respectively.
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However, these associations do not guarantee a causal 
relationship. It is possible that a low SBP could be a conse-
quence of concurrent frailty or chronic disease, even though 
the participants in our study constituted a nonclinical popula-
tion with no known preexisting diseases, such as cancer, heart 
disease, or stroke. Furthermore, the population of the current 
study was generally healthier than the average Korean popu-
lation.17 Because individuals with underlying conditions who 
have a low SBP, even if undiagnosed at the time of study entry, 
may die prematurely, we additionally excluded patients who 
died during the first 5 years of follow-up. After such exclu-
sion, the relative risk of mortality associated with low SBP 
increased, albeit modestly, relative to those of the main analy-
sis. Therefore, reverse causality may not be solely responsible 
for the association between low SBP and death from vascular 
disease. However, because a comprehensive cardiovascular 
evaluation was not conducted for each participant, the possi-
bility of some of the participants with the lowest SBP having 
undiagnosed cardiovascular disease and taking BP-lowering 
medications cannot be completely ruled out.
Second, in recent studies involving individuals with vari-
ous diseases, index event bias (or collider-stratification bias) 
has been suggested as an explanation for the seemingly 
paradoxical associations.4,24–26 This study included healthy 
individuals without evident cardiovascular diseases24–26 and 
adjusted for most major risk factors for vascular disease4; 
thus, the observed associations are unlikely to be the result of 
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Figure 1. Sex- and age-adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group. Eight 
categories of SBP (reference, 90–99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. A different y-axis scale was used for all-cause mortality 
and vascular mortality. CI indicates confidence interval.






Yi et al  Low Systolic Blood Pressure and Vascular Mortality  2385
Table 2. Multivariable Adjusted* HRs for All-Cause and Cardiovascular Mortality by SBP Group 
Causes of Death (ICD-10) SBP Groups, mm Hg No. of Deaths Death Rate† P Value HR (95% CI)
Any cause <90 302 931 0.007 1.18 (1.05–1.33)
90–99 2253 580 1.00 (Reference)
100–109 8963 449 0.122 0.96 (0.92–1.01)
110–119 22 693 426 0.075 0.96 (0.92–1.00)
120–139 63 011 592 0.023 1.05 (1.01–1.10)
140–159 37 636 1148 <0.001 1.25 (1.19–1.30)
160–179 14 368 1852 <0.001 1.48 (1.42–1.55)
≥180 5656 2422 <0.001 1.73 (1.65–1.82)
Atherosclerotic vascular 
diseases (I10–I15, I20–I25, 
I44–I52, I60–I69, I70–I74, R96)
<90 57 176 0.003 1.53 (1.15–2.03)
90–99 326 84 1.00 (Reference)
100–109 1355 68 0.525 1.04 (0.92–1.17)
110–119 3631 68 0.035 1.13 (1.01–1.27)
120–139 12 474 117 <0.001 1.50 (1.34–1.67)
140–159 10 012 305 <0.001 2.25 (2.01–2.51)
160–179 4706 606 <0.001 3.13 (2.8–3.5)
≥180 2255 966 <0.001 4.30 (3.83–4.84)
Ischemic heart diseases 
(I20–I25)
<90 18 55 <0.001 2.54 (1.51–4.29)
90–99 64 16 1.00 (Reference)
100–109 357 18 0.052 1.30 (1–1.7)
110–119 975 18 0.020 1.35 (1.05–1.74)
120–139 3254 31 <0.001 1.71 (1.34–2.2)
140–159 2306 70 <0.001 2.35 (1.83–3.02)
160–179 1009 130 <0.001 3.19 (2.47–4.11)
≥180 391 167 <0.001 3.63 (2.78–4.74)
Total stroke (I60–I69)
<90 24 74 0.384 1.21 (0.79–1.85)
90–99 172 44 1.00 (Reference)
100–109 683 34 0.908 1.01 (0.85–1.19)
110–119 1897 36 0.068 1.16 (0.99–1.35)
120–139 6668 63 <0.001 1.58 (1.36–1.84)
140–159 5807 177 <0.001 2.55 (2.19–2.97)
160–179 2848 367 <0.001 3.66 (3.14–4.27)
≥180 1439 616 <0.001 5.28 (4.5–6.19)
Ischemic stroke (I63)
<90 5 15 0.557 0.76 (0.31–1.9)
90–99 57 15 1.00 (Reference)
100–109 197 10 0.427 0.89 (0.66–1.19)
110–119 535 10 0.984 1.00 (0.76–1.32)
120–139 1949 18 0.022 1.36 (1.05–1.77)
140–159 1650 50 <0.001 1.99 (1.53–2.6)
160–179 788 102 <0.001 2.70 (2.06–3.54)
≥180 442 189 <0.001 4.23 (3.2–5.58)
Hemorrhagic stroke (I60–I62)
<90 7 22 0.230 1.64 (0.73–3.66)
90–99 39 10 1.00 (Reference)
100–109 212 11 0.128 1.30 (0.93–1.84)
(Continued )
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participants with preexisting diseases, with no conditioning 
on the manifest cardiovascular disease status (namely, no 
adjustment for disease status), was done to minimize collider-
stratification bias and increase generalizability,24,26 the associ-
ation between vascular mortality and low SBP did not weaken 
(Figure XI in the online-only Data Supplement). Meanwhile, 
in additional analysis among people with known preexisting 
cardiovascular diseases (n=15 277), the inverse association in 
the low-SBP range was stronger than that in the healthy popu-
lation (Figure XII in the online-only Data Supplement).
Third, a wide pulse pressure, rather than a low DBP, has 
been suggested as 1 possible explanation for the J-curve asso-
ciations.27 Because our study analyzed the SBP, where the 
wide pulse pressure hypothesis is irrelevant, and the associa-
tions with low SBP were maintained after additional adjust-
ment for pulse pressure in the current study, and in previous 
research, as well,2,5 a wide pulse pressure cannot explain the 
J-curve associations between SBP and vascular mortality.
The findings of a strong association of low SBP with death 
from ischemic heart disease and a weak association with death 
from stroke are consistent with the results of previous research 
conducted on individuals with vascular disease,2,4–6 and on the 
nonclinical populations, as well.13,14 However, the association 
observed between low SBP and stroke mortality, for exam-
ple, the inverse association of SBP <100 mm Hg in people 
aged 60 to 95 years, may conflict with the results of previous 
research.2,4,6 This inconsistency may be mainly attributable to 
the differences in the subtype of stroke common to Korean 
populations versus European populations. According to 
Korean national mortality statistics, hemorrhagic stroke was a 
leading subtype of stroke mortality up until 2001. In younger 
populations (eg, those <70 years), the same is true in the pres-
ent day. Of our participants, more individuals died of hemor-
rhagic stroke (n=6112) than of ischemic stroke (n=5623). In 
contrast, ischemic stroke accounts for the majority of strokes 
in populations of European origin.28,29 In the current study, the 
HR associated with an SBP <90 mm Hg was 1.65 (95% CI, 
0.74–3.69) for mortality from hemorrhagic stroke, but was 
0.75 (95% CI, 0.30–1.88) for ischemic stroke mortality in 
all participants. In the range <100 mm Hg, each 10 mm Hg 
increase in SBP was inversely associated with mortality from 
hemorrhagic stroke (HR, 0.53; 95% CI, 0.29–0.96), but not 
from ischemic stroke (HR, 1.00; 95% CI, 0.51–1.97).
In addition, the positive association of SBP <90 mm Hg 
with vascular mortality in comparison with the reference 
group, and the inverse associations of SBP with vascular mor-
tality in the range <100 mm Hg, were statistically significant in 
participants aged 60 to 95 years, but not in their younger coun-
terparts, in accordance with previous results.4,13,14 However, it 
cannot be stated conclusively that the association in the range 
<100 mm Hg in people aged 30 to 59 years was different from 
that in people aged 60 to 95 years, especially for ischemic 
heart disease mortality, because the P values for the interac-
tion between age and SBP were >0.05.
Association of Low DBP and Low Pulse Pressure 
With Vascular Mortality
In the general population, the associations of DBP and pulse 
pressure with vascular mortality have been shown to be weaker 
than the associations of SBP with vascular mortality.1,15,16 In an 
additional analysis of our data, there was some evidence to sug-
gest J-curve associations between DBP and atherosclerotic vas-
cular mortality. However, the J-curve associations of DBP per 
se were weaker than those of SBP, in contrast to several stud-
ies on patients with manifest cardiovascular diseases,2,4 and the 
associations disappeared or were substantially weakened after 
adjustment for SBP (Figures XIII through XV in the online-only 
Data Supplement). Pulse pressure seemed to have no apparent 
J-curve association with atherosclerotic vascular mortality 
(Figures XVI and XVII in the online-only Data Supplement).
Potential Mechanisms
An SBP <90 mm Hg may lead to hypoperfusion of the cor-
onary arteries and thus cause cardiac events that then result 
in death from ischemic heart disease. In cases of ischemic 
stroke, although a low SBP (<90 mm Hg) may cause a reduc-
tion in cognitive performance,30 it may not be sufficiently low 
to cause ischemic brain injury because a mean atrial pressure 
>45 to 50 mm Hg may be sufficient for brain survival.31 For 
a hemorrhagic stroke, resulting from the mass effect from 
hematoma expansion and perihemorrhagic edema, an elevated 
intracranial pressure can increase the intracranial venous pres-
sure.32,33 A low SBP that cannot compensate for the increase 
in venous pressure may result in insufficient perfusion of the 
brain tissue and subsequent death.32 Furthermore, systolic 
hypotension <90 mm Hg is well known to be a poor prognos-
tic factor in patients with traumatic brain injury, which can 
also cause intracranial hemorrhage.34 Meanwhile, the mecha-
nisms through which low SBP may cause hemorrhagic stroke 
are currently unclear.
110–119 678 13 0.002 1.66 (1.2–2.3)
120–139 2207 21 <0.001 2.26 (1.64–3.1)
140–159 1778 54 <0.001 3.90 (2.84–5.36)
160–179 799 103 <0.001 5.57 (4.03–7.7)
≥180 392 168 <0.001 8.14 (5.85–11.33)
CI indicates confidence interval; HR, hazard ratio; ICD-10, International Classification of Diseases, 10th Revision; and SBP, systolic blood pressure.
*Adjustment for age at entry (continuous), sex, smoking status (never, former, current smoker), alcohol intake (g/d; 0, 1–20, >20), physical activity (yes, no), total 
cholesterol (mg/dL; continuous), fasting serum glucose (mg/dL; continuous), and BMI (kg/m2; continuous).
†Crude death rate per 100 000 person-years
Table 2. Continued
Causes of Death (ICD-10) SBP Groups, mm Hg No. of Deaths Death Rate† P Value HR (95% CI)
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Strengths and Limitations of This Study
The strengths of this study include its prospective design, a 
large number of participants, long-term duration, complete 
follow-up, and a homogeneous ethnic group. It also has sev-
eral limitations. First, the procedure with which BP measure-
ments were taken for the current study may not be ideal; there 
are higher published standards for BP research.35 However, 
because the potential errors in the BP measurements are 
mostly likely to be random according to vascular mortality,36,37 
overestimation of the relative risk associated with a low SBP 
is unlikely to be a major concern. Second, BP was measured 
only once. Thus, the relative risks associated with SBP may 
be underestimated in the current study because of a regression 
dilution bias.38 Third, the causes of death were not verified 
independent from national death records. However, in Korea, 
cause of death on the death certificate was reported to be rea-
sonably valid in comparison with medical records.20 In addi-
tion, because potential misclassification tends not to depend 
on SBP, this issue is unlikely to cause an overestimation of 
the risk associated with low SBP.39 Fourth, despite the large 
Figure 2. Multivariable adjusted hazard ratios for all-cause and vascular mortality by restricted cubic splines of systolic blood pressure 
(SBP) with 5 knots (80, 90, 100, 110, and 120 mm Hg) and 90 mm Hg as a reference. Adjustment was made for age at entry, sex, smoking 
status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. CI indicates confidence interval.
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number of participants, the number of cause-specific vascular 
deaths in those with the lowest SBP was small, which may 
result in a decreased statistical power in some of the analy-
ses. Fifth, given the observational nature of the study, definite 
causal inference is limited. In addition, although persons with 
self-reported hypertension, heart disease, stroke, cancer, liver 
disease, or respiratory disease were excluded from the study, 
lack of information on several potential confounders such as 
Figure 3. Multivariable adjusted hazard ratios for all-cause and vascular mortality by systolic blood pressure (SBP) group according to age. 
Eight categories of SBP (reference, 90–99 mm Hg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, 
alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass index. No death was observed from ischemic stroke 
in persons aged 30 to 59 years with SBP 60 to 89 mm Hg. A different y-axis scale was used for all-cause mortality and vascular mortality. The 
numeric version of this figure is available in Table III in the online-only Data Supplement. CI indicates confidence interval.
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BP medication use, and detailed cardiovascular and other dis-
ease status, is another limitation. Finally, the generalizability 
of the findings to the global population may be limited because 
all participants were Korean. Further research is thus needed 
to confirm whether this J-curve association exists among 
other ethnic groups. It is also worth mentioning that our study 
population is healthier and has a higher socioeconomic status 
(employees of the government or schools, or their dependents) 
than the general population in Korea.17 We do not, however, 
think that the expected low death rate of a healthier popula-
tion substantially impacts the association between SBP and 
vascular mortality.
Conclusion
In healthy Korean adults, a J-curve association exists between 
SBP and all-cause and vascular mortality. In persons with SBP 
>100 mm Hg, increases in SBP increase vascular mortality, 
whereas in persons with SBP <90 mm Hg, decreases in SBP 
are associated with higher vascular mortality, especially mor-
tality from ischemic heart disease. Death from hemorrhagic 
stroke may also be associated with low SBP. Therefore, indi-
viduals with low SBPs should be clinically followed. Further 
research is required to confirm this association in other ethnic/
regional populations.
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CLINICAL PERSPECTIVE
Physicians often ignore low blood pressure. Previous research suggests that low blood pressure is a predictor of mortality in 
the elderly and in individuals with vascular or other diseases. However, it is unclear whether and in what range low blood 
pressure increases the risk of death from any cause and from vascular diseases, especially in healthy general populations. The 
current prospective cohort study that includes 1 235 246 healthy Korean adults aged 30 to 95 years with 20 years of follow-up 
demonstrated that low systolic blood pressure (SBP) increases overall and vascular mortality. The association between low 
SBP (>90 mm Hg) and vascular mortality was prominent for ischemic heart disease, whereas it was weak for total stroke. 
Death from hemorrhagic stroke may also be related to low SBP. Our study establishes low SBP as a risk factor for death 
from vascular diseases or any cause in a general population. Therefore, individuals with low SBPs should not be ignored, but 
should be clinically followed to ensure better health and to minimize death from vascular diseases and other causes.
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Supplemental Table 1. ICD-10 code and related diseases analyzed in the study. 
ICD-10 code Diseases 
I10-I15 Hypertensive diseases 
  I10 Essential (primary) hypertension 
  I11 Hypertensive heart disease 
  I12 Hypertensive renal disease 
  I13 Hypertensive heart and renal disease 
  I15 Secondary hypertension 
I20-I25 Ischemic heart diseases 
  I20 Angina pectoris 
  I21 Acute myocardial infarction 
  I22 Subsequent myocardial infarction 
  I23 Certain current complications following acute myocardial  infarction 
  I24 Other acute ischemic heart diseases 
  I25 Chronic ischemic heart disease 
I44-I52 other forms of heart disease likely related to atherosclerosis 
  I44 Atrioventricular and left bundle-branch block 
  I45 Other conduction disorders 
  I46 Cardiac arrest 
  I47 Paroxysmal tachycardia 
  I48 Atrial fibrillation and flutter 
  I49 Other cardiac arrhythmias 
  I50 Heart failure 
  I51 Complications and ill-defined descriptions of heart disease 
  I52 Other heart disorders in diseases classified elsewhere 
I60-I69 Total stroke 
  I60 Subarachnoid haemorrhage 
  I61 Intracerebral haemorrhage 
  I62 Other nontraumatic intracranial haemorrhage 
  I63 Cerebral infarction 
  I64 Stroke, not specified as haemorrhage or infarction 
  I65 Occlusion and stenosis of precerebral arteries, not resulting  in cerebral infarction 
  I66 Occlusion and stenosis of cerebral arteries, not resulting in  cerebral infarction 
  I67 Other cerebrovascular diseases 
  I68 Cerebrovascular disorders in diseases classified elsewhere 
  I69 Sequele of cerebrovascular disease 
I70-I74 Diseases of arteries 
  I70 Atherosclerosis 
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  I71 Aortic aneurysm and dissection 
  I72 Other aneurysm and dissection 
  I73 Other peripheral vascular diseases 
  I74 Arterial embolism and thrombosis 
R96 Other sudden death, cause unknown 





Supplemental Table 2. Baseline characteristics and follow-up years by category of systolic blood pressure 
 (SBP; mm Hg) < 90 90-99 100-109 110-119 120-139 140-159 160-179 ≥180  
Variables Classification n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) p-value 
Participants Number (%)a 1,862 (0.2) 21,414 (1.7) 107,283 (8.7) 283,313 (22.9) 573,091 (46.4) 186,067 (15.1) 47,204 (3.8) 15,012 (1.2)  
Person-years Person-year (%)a 32,450 (0.1) 388,778 (1.7) 1,997,605 (8.8) 5,327,718 (23.5) 10,640,094 (46.9) 3,278,231 (14.5) 775,934 (3.4) 233,489 (1.0) <0.001 
Age Mean (SD), years old 51.2 (11.5) 46.9 (11.8) 44.2 (11.2) 43.5 (10.6) 45.8 (11.1) 51.8 (11.4) 56.7 (10.7) 58.8 (10.3) <0.001 
SBP Mean (SD), mm Hg 80.3 (3.3) 90.4 (1.5) 100.2 (1.2) 110.1 (0.8) 124.2 (5.0) 143.1 (4.7) 163.4 (4.8) 187.9 (11.8) <0.001 
DBP Mean (SD), mm Hg 53.8 (7.0) 60.2 (5.2) 65.6 (6.3) 72.0 (5.6) 81.4 (6.9) 90.9 (8.0) 100.8 (10.5) 110.4 (14.1) <0.001 
BMI (kg/m2) Mean (SD) 21.7 (2.8) 21.9 (2.7) 22.1 (2.6) 22.6 (2.6) 23.4 (2.7) 24.1 (2.9) 24.4 (3.1) 24.6 (3.2) <0.001 
Total cholesterolb Mean (SD), mg/dL 184.4 (36.1) 184.5 (36.8) 185.1 (36.4) 187.5 (36.7) 192.8 (38.0) 199.8 (40.1) 203.9 (41.7) 206.1 (42.7) <0.001 
Fasting glucosec Mean (SD), mg/dL 88.3 (22.1) 87.9 (22.0) 88.2 (21.4) 89.0 (21.0) 91.9 (23.9) 96.7 (29.2) 99.6 (32.4) 101.3 (34.4) <0.001 
Sex Women 1,393 (74.8) 15,124 (70.6) 60,609 (56.5) 111,796 (39.5) 169,852 (29.6) 59,503 (32.0) 19,835 (42.0) 7,127 (47.5) <0.001 
 Men 469 (25.2) 6,290 (29.4) 46,674 (43.5) 171,517 (60.5) 403,239 (70.4) 126,564 (68.0) 27,369 (58.0) 7,885 (52.5)  
Exercise No 1,529 (82.1) 17,467 (81.6) 86,204 (80.4) 221,345 (78.1) 430,424 (75.1) 133,125 (71.5) 33,638 (71.3) 10,742 (71.6) <0.001 
 Yes 333 (17.9) 3,947 (18.4) 21,079 (19.6) 61,968 (21.9) 142,667 (24.9) 54,942 (29.5) 13,566 (28.7) 4,270 (28.4)  
Smoking Current smoker 430 (23.1) 4,832 (22.6) 31,440 (29.3) 109,058 (38.5) 245,139 (42.8) 73,223 (39.4) 15,276 (32.4) 4,310 (28.7) <0.001 
 Never smoker 1,310 (70.4) 15,140 (70.7) 66,410 (61.9) 140,317 (49.5) 243,541 (42.5) 82,317 (44.2) 24,223 (51.3) 8,357 (55.7)  
 Past smoker 122 (6.6) 1,442 (6.7) 9,433 (8.8) 33,938 (12.0) 84,411 (14.7) 30,527 (16.4) 7,705 (16.3) 2,345 (15.6)  
Drinking, 0 1,414 (75.9) 15,196 (71.0) 65,567 (61.1) 139,046 (49.1) 234,924 (41.0) 78,252 (42.1) 23,283 (49.3) 8,061 (53.7) <0.001 
g ethanol/day 1-19 416 (22.3) 5,295 (24.7) 31,578 (29.4) 98,740 (34.9) 214,901 (37.5) 68,413 (36.8) 16,330 (34.6) 4,971 (33.1)  
 ≥ 20 32 (1.7) 923 (4.3) 10,138 (9.4) 45,527 (16.1) 123,266 (21.5) 39,402 (21.2) 7,591 (16.1) 1,980 (13.2)  
Abbreviation: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation. 
* The percent value is calculated using the number in each SBP category compared to that in all participants.  
† To convert glucose from mg/dL to mmol/L, multiply by 0.0555 
‡ To convert cholesterol from mg/dL to mmol/L, multiply by 0.0259 
P-values were calculated by chi-squared tests and one-way analysis of variance between eight SBP groups 
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Supplemental Table 3. HRs* for all-cause and vascular mortality by SBP group 
according to age (Numerical version of Figure 3). 
  60-95 years (n=177,790) 30-59 years (n=1,057,456) 













p-value HR (95% CI) 
Any cause <90 211 3,260 0.017 1.19 (1.03-1.38) 91 350 0.386 1.10 (0.89-1.37) 
 90-99 1,402 2,730 1.00 (Reference) 851 252  1.00 (Reference)
 100-109 4,666 2,627 0.540 0.98 (0.93-1.04) 4,297 236 0.129 0.95 (0.88-1.02) 
 110-119 9,758 2,565 0.364 0.97 (0.92-1.03) 12,935 261 0.148 0.95 (0.89-1.02) 
 120-139 28,208 2,739 0.288 1.03 (0.98-1.09) 34,803 362 0.108 1.06 (0.99-1.13) 
 140-159 20,829 3,152 <0.001 1.16 (1.09-1.22) 16,807 642 <0.001 1.34 (1.25-1.43) 
 160-179 9,275 3,704 <0.001 1.34 (1.27-1.42) 5,093 969 <0.001 1.70 (1.58-1.83) 
 ≥180 3,830 4,338 <0.001 1.53 (1.44-1.63) 1,826 1258 <0.001 2.14 (1.97-2.32) 
Atherosclerotic <90 44 680 0.006 1.57 (1.14-2.17) 13 50 0.400 1.28 (0.72-2.28) 
vascular diseases 90-99 223 434 1.00 (Reference) 103 31  1.00 (Reference)
(I10-I15, I20-I25,  100-109 863 486 0.096 1.13 (0.98-1.31) 492 27 0.394 0.91 (0.74-1.13) 
I44-I52, I60-I69,  110-119 2,075 545 <0.001 1.29 (1.12-1.48) 1,556 31 0.714 0.96 (0.79-1.18) 
I70-I74, R96) 120-139 6,824 663 <0.001 1.55 (1.35-1.77) 5,650 59 0.001 1.41 (1.16-1.72) 
 140-159 6,064 918 <0.001 2.06 (1.8-2.35) 3,948 151 <0.001 2.49 (2.04-3.03) 
 160-179 3,185 1,272 <0.001 2.77 (2.42-3.17) 1,521 289 <0.001 3.92 (3.2-4.79) 
 ≥180 1,528 1,731 <0.001 3.63 (3.15-4.18) 727 501 <0.001 6.45 (5.24-7.94) 
Ischemic heart  <90 14 216 0.003 2.51 (1.38-4.57) 4 15 0.140 2.25 (0.77-6.62) 
diseases 90-99 45 88 1.00 (Reference) 19 6  1.00 (Reference)
(I20-I25) 100-109 202 114 0.125 1.29 (0.93-1.78) 155 9 0.165 1.40 (0.87-2.26) 
 110-119 463 122 0.044 1.37 (1.01-1.86) 512 10 0.118 1.44 (0.91-2.28) 
 120-139 1,468 143 0.004 1.55 (1.15-2.09) 1,786 19 0.003 1.98 (1.26-3.11) 
 140-159 1,234 187 <0.001 1.94 (1.44-2.62) 1,072 41 <0.001 3.01 (1.91-4.75) 
 160-179 651 260 <0.001 2.65 (1.95-3.59) 358 68 <0.001 4.21 (2.65-6.69) 
 ≥180 234 265 <0.001 2.61 (1.89-3.59) 157 108 <0.001 6.43 (3.99-10.38)
Total Stroke <90 20 309 0.195 1.37 (0.85-2.2) 4 15 0.493 0.70 (0.25-1.93) 
(I60-I69) 90-99 116 226 1.00 (Reference) 56 17  1.00 (Reference)
 100-109 466 262 0.113 1.18 (0.96-1.45) 217 12 0.110 0.79 (0.59-1.06) 
 110-119 1,176 309 <0.001 1.41 (1.16-1.71) 721 15 0.525 0.92 (0.7-1.2) 
 120-139 3,917 380 <0.001 1.71 (1.42-2.06) 2,751 29 0.008 1.43 (1.1-1.87) 
 140-159 3,593 544 <0.001 2.37 (1.97-2.85) 2,214 85 <0.001 2.86 (2.19-3.74) 
 160-179 1,913 764 <0.001 3.23 (2.68-3.9) 935 178 <0.001 4.85 (3.7-6.37) 
 ≥180 986 1,117 <0.001 4.57 (3.77-5.54) 453 312 <0.001 8.03 (6.07-10.62)
Ischemic Stroke <90 5 77 0.929 1.04 (0.41-2.65) 0 0  0.00  
(I63) 90-99 39 76 1.00 (Reference) 18 5  1.00 (Reference)
 100-109 148 83 0.615 1.10 (0.77-1.56) 49 3 0.028 0.55 (0.32-0.94) 
 110-119 376 99 0.121 1.30 (0.93-1.81) 159 3 0.051 0.61 (0.38-1) 
 120-139 1,310 127 0.003 1.62 (1.18-2.23) 639 7 0.809 0.94 (0.59-1.51) 
 140-159 1,123 170 <0.001 2.06 (1.49-2.84) 527 20 0.020 1.76 (1.1-2.83) 
 160-179 579 231 <0.001 2.72 (1.96-3.77) 209 40 <0.001 2.68 (1.65-4.35) 
 ≥180 327 370 <0.001 4.20 (3.01-5.86) 115 79 <0.001 4.99 (3.03-8.25) 
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Hemorrhagic  <90 5 77 0.155 2.04 (0.76-5.48) 2 8 0.934 1.06 (0.25-4.55) 
Stroke 90-99 19 37 1.00 (Reference) 20 6  1.00 (Reference)
(I60-I62) 100-109 108 61 0.034 1.70 (1.04-2.76) 104 6 0.887 1.04 (0.64-1.67) 
 110-119 303 80 0.001 2.28 (1.44-3.63) 375 8 0.223 1.32 (0.84-2.08) 
 120-139 913 89 <0.001 2.57 (1.63-4.05) 1,294 13 0.002 2.01 (1.29-3.13) 
 140-159 858 130 <0.001 3.74 (2.37-5.9) 920 35 <0.001 3.97 (2.54-6.19) 
 160-179 427 171 <0.001 4.83 (3.05-7.66) 372 71 <0.001 6.78 (4.31-10.67)
 ≥180 218 247 <0.001 6.88 (4.3-11.01) 174 120 <0.001 10.97 (6.88-17.47)
Abbreviation: CI, confidence interval; HR, hazard ratio; ICD-10, International Classification of Diseases, 10th revision; SBP, systolic blood 
pressure 
* Adjustment for age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/day; 0, 1-20, >20); physical 
activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m2; continuous). 




Supplemental Table 4. HRs* per 10 mmHg increase in SBP for vascular mortality given 
SBP range. 




HR for each 10 mmHg 
increase in SBP  
(95% CI) 
In the range SBP < 100 mmHg  
Any cause 2,555 0.014 0.88 (0.80-0.97) 
Atherosclerotic vascular diseases 383 0.002 0.70 (0.56-0.88) 
Ischemic heart diseases 82 0.001 0.50 (0.34-0.75) 
Total Stroke 196 0.172 0.79 (0.56-1.11) 
Ischemic Stroke 62 0.994 1.00 (0.51-1.97) 
Hemorrhagic stroke 46 0.038 0.53 (0.29-0.96) 
   
In the range SBP ≥ 100 mmHg   
Any cause 152,327 <0.001 1.08 (1.08-1.08) 
Atherosclerotic vascular diseases 34,433 <0.001 1.19 (1.19-1.20) 
Ischemic heart diseases 8,292 <0.001 1.15 (1.14-1.16) 
Total Stroke 19,342 <0.001 1.22 (1.21-1.23) 
Ischemic Stroke 5,561 <0.001 1.20 (1.18-1.21) 
Hemorrhagic stroke 6,066 <0.001 1.24 (1.23-1.25) 
Abbreviation: CI, confidence interval; HR, hazard ratio; SBP, systolic blood pressure 
* Adjustment for age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/day; 0, 1-20, >20); physical 







Supplemental Table 5. HRs* per 10 mmHg increase in SBP for vascular mortality across 
SBP ranges stratified by age group.  
 60-95 years 30-59 years  





HR for each 10 
mmHg increase 




HR for each 10 
mmHg increase 
in SBP (95% CI) 
p for 
interaction†
In the range SBP < 100 mmHg     
Any cause 1,613 0.019 0.87 (0.77-0.98) 942 0.427 0.93 (0.77-1.12) 0.502 
Atherosclerotic vascular diseases 267 0.001 0.65 (0.50-0.84) 116 0.664 0.89 (0.53-1.49) 0.939 
Ischemic heart diseases 59 0.001 0.48 (0.31-0.75) 23 0.147 0.51 (0.21-1.27) 0.792 
Total Stroke 136 0.030 0.66 (0.46-0.96) 60 0.284 1.59 (0.68-3.69) 0.310 
Ischemic Stroke 44 0.443 0.76 (0.37-1.54) 18 0.174 3.24 (0.6-17.64) 0.482 
Hemorrhagic stroke 24 0.026 0.44 (0.21-0.90) 22 0.555 0.72 (0.24-2.18) 0.992 
      
In the range SBP ≥ 100 mmHg      
Any cause 76,566 <0.001 1.06 (1.05-1.06) 75,761 <0.001 1.11 (1.11-1.12) <0.001 
Atherosclerotic vascular diseases 20,539 <0.001 1.15 (1.14-1.16) 13,894 <0.001 1.28 (1.27-1.29) <0.001 
Ischemic heart diseases 4,252 <0.001 1.11 (1.09-1.13) 4,040 <0.001 1.21 (1.19-1.23) <0.001 
Total Stroke 12,051 <0.001 1.17 (1.16-1.18) 7,291 <0.001 1.33 (1.32-1.34) <0.001 
Ischemic Stroke 3,863 <0.001 1.16 (1.14-1.17) 1,698 <0.001 1.30 (1.27-1.33) <0.001 
Hemorrhagic stroke 2,827 <0.001 1.16 (1.15-1.18) 3,239 <0.001 1.33 (1.31-1.35) <0.001 
Abbreviation: CI, confidence interval; HR, hazard ratio; SBP, systolic blood pressure 
* Adjustment for age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/day; 0, 1-20, >20); physical 
activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m2; continuous). 






Supplemental Table 6. HRs* per 10 mmHg increase in SBP for vascular mortality across 
SBP ranges stratified by sex.  
 Men Women  





HR for each 10 
mmHg increase 




HR for each 10 
mmHg increase 
in SBP (95% CI) 
p for 
interaction†
In the range SBP < 100 mmHg     
Any cause 1,362 0.034 0.86 (0.75-0.99) 1,193 0.247 0.92 (0.79-1.06) 0.696 
Atherosclerotic vascular diseases 167 0.073 0.72 (0.50-1.03) 216 0.016 0.69 (0.51-0.93) 0.891 
Ischemic heart diseases 39 0.011 0.46 (0.25-0.84) 43 0.037 0.56 (0.32-0.96) 0.661 
Total Stroke 87 0.884 1.04 (0.59-1.86) 109 0.042 0.64 (0.42-0.98) 0.220 
Ischemic Stroke 30 0.395 1.64 (0.53-5.12) 32 0.419 0.71 (0.31-1.63) 0.247 
Hemorrhagic stroke 17 0.144 0.47 (0.17-1.29) 29 0.111 0.53 (0.24-1.16) 0.825 
      
In the range SBP ≥ 100 mmHg      
Any cause 104,560 <0.001 1.09 (1.08-1.09) 47,767 <0.001 1.07 (1.06-1.07) <0.001 
Atherosclerotic vascular diseases 21,270 <0.001 1.22 (1.21-1.23) 13,163 <0.001 1.16 (1.15-1.17) <0.001 
Ischemic heart diseases 5,709 <0.001 1.17 (1.15-1.18) 2,583 <0.001 1.13 (1.11-1.15) 0.611 
Total Stroke 11,549 <0.001 1.26 (1.25-1.27) 7,793 <0.001 1.18 (1.17-1.19) <0.001 
Ischemic Stroke 3,335 <0.001 1.23 (1.21-1.25) 2,226 <0.001 1.16 (1.14-1.18) <0.001 
Hemorrhagic stroke 3,671 <0.001 1.28 (1.26-1.30) 2,395 <0.001 1.20 (1.18-1.22) 0.005 
Abbreviation: CI, confidence interval; HR, hazard ratio; SBP, systolic blood pressure 
* Adjustment for age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/day; 0, 1-20, >20); physical 
activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m2; continuous). 





Supplemental Table 7. HRs* for all-cause and vascular mortality by SBP group 
according to sex 
  Men (n=790,007) Women (n=445,239) 













p-value HR (95% CI) 
Any cause <90 165 2,222 0.009 1.24 (1.06-1.46) 137 547 0.290 1.10 (0.92-1.32) 
 90-99 1,197 1,083 1.00 (Reference) 1,056 379  1.00 (Reference)
 100-109 5,356 617 0.003 0.91 (0.86-0.97) 3,609 319 0.904 1.00 (0.93-1.07) 
 110-119 15,461 476 <0.000 0.87 (0.82-0.93) 7,232 348 0.515 1.02 (0.96-1.09) 
 120-139 45,459 601 0.183 0.96 (0.91-1.02) 17,554 570 0.002 1.10 (1.04-1.17) 
 140-159 26,148 1,158 <0.001 1.17 (1.11-1.24) 11,488 1,125 <0.001 1.26 (1.18-1.34) 
 160-179 8,850 1,956 <0.001 1.38 (1.3-1.47) 5,518 1,706 <0.001 1.53 (1.43-1.64) 
 ≥180 3,286 2,694 <0.001 1.66 (1.55-1.77) 2,370 2,125 <0.001 1.69 (1.57-1.82) 
Atherosclerotic <90 22 296 0.174 1.37 (0.87-2.14) 35 140 0.008 1.63 (1.13-2.34) 
vascular diseases 90-99 145 131 1.00 (Reference) 181 65  1.00 (Reference)
(I10-I15, I20-I25,  100-109 706 81 0.935 1.01 (0.84-1.2) 649 57 0.590 1.05 (0.89-1.23) 
I44-I52, I60-I69,  110-119 2,194 68 0.563 1.05 (0.89-1.24) 1,437 69 0.044 1.17 (1-1.37) 
I70-I74, R96) 120-139 8,036 106 <0.001 1.40 (1.19-1.65) 4,439 144 <0.001 1.56 (1.34-1.81) 
 140-159 6,438 285 <0.001 2.26 (1.92-2.67) 3,574 350 <0.001 2.09 (1.8-2.43) 
 160-179 2,645 585 <0.001 3.13 (2.65-3.7) 2,061 637 <0.001 3.00 (2.57-3.5) 
 ≥180 1,251 1,026 <0.001 4.72 (3.97-5.6) 1,004 900 <0.001 3.69 (3.15-4.33) 
Ischemic heart  <90 8 108 0.023 2.46 (1.13-5.35) 10 40 0.009 2.57 (1.27-5.22) 
diseases 90-99 31 28 1.00 (Reference) 33 12  1.00 (Reference)
(I20-I25) 100-109 207 24 0.215 1.27 (0.87-1.85) 150 13 0.1614 1.31 (0.9-1.91) 
 110-119 683 21 0.121 1.33 (0.93-1.91) 292 14 0.195 1.27 (0.89-1.82) 
 120-139 2,348 31 0.005 1.66 (1.17-2.37) 906 29 0.004 1.67 (1.18-2.37) 
 140-159 1,648 73 <0.001 2.46 (1.73-3.52) 658 64 <0.001 1.99 (1.4-2.83) 
 160-179 590 130 <0.001 3.10 (2.16-4.46) 419 130 <0.001 3.15 (2.21-4.5) 
 ≥180 233 191 <0.001 3.96 (2.72-5.77) 158 142 <0.001 2.98 (2.04-4.36) 
Total Stroke <90 7 94 0.510 0.77 (0.36-1.67) 17 68 0.091 1.56 (0.93-2.62) 
(I60-I69) 90-99 80 72 1.00 (Reference) 92 33  1.00 (Reference)
 100-109 324 37 0.262 0.87 (0.68-1.11) 359 32 0.260 1.14 (0.91-1.43) 
 110-119 1,061 33 0.851 0.98 (0.78-1.23) 836 40 0.006 1.35 (1.09-1.68) 
 120-139 4,063 54 0.007 1.36 (1.09-1.69) 2,605 85 <0.001 1.84 (1.49-2.26) 
 140-159 3,680 163 <0.001 2.42 (1.94-3.02) 2,127 208 <0.001 2.55 (2.06-3.14) 
 160-179 1,628 360 <0.001 3.54 (2.82-4.43) 1,220 377 <0.001 3.65 (2.95-4.52) 
 ≥180 793 650 <0.001 5.45 (4.32-6.86) 646 579 <0.001 4.93 (3.96-6.15) 
Ischemic Stroke <90 1 13 0.245 0.31 (0.04-2.25) 4 16 0.741 1.19 (0.42-3.4) 
(I63) 90-99 29 26 1.00 (Reference) 28 10  1.00 (Reference)
 100-109 87 10 0.068 0.68 (0.44-1.03) 110 10 0.556 1.13 (0.75-1.72) 
 110-119 304 9 0.377 0.84 (0.58-1.23) 231 11 0.382 1.19 (0.81-1.76) 
 120-139 1,193 16 0.450 1.15 (0.8-1.67) 756 25 0.012 1.62 (1.11-2.36) 
 140-159 1,054 47 0.001 1.86 (1.28-2.69) 596 58 <0.001 2.05 (1.4-2.99) 
 160-179 446 99 <0.001 2.48 (1.7-3.62) 342 106 <0.001 2.88 (1.96-4.25) 
 ≥180 251 206 <0.001 4.34 (2.95-6.38) 191 171 <0.001 3.98 (2.67-5.94) 
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Hemorrhagic  <90 2 27 0.758 1.26 (0.29-5.51) 5 20 0.215 1.84 (0.7-4.82) 
Stroke 90-99 15 14 1.00 (Reference) 24 9  1.00 (Reference)
(I60-I62) 100-109 100 12 0.481 1.22 (0.71-2.09) 112 10 0.184 1.35 (0.87-2.1) 
 110-119 376 12 0.182 1.42 (0.85-2.39) 302 15 0.003 1.89 (1.24-2.86) 
 120-139 1,395 18 0.007 2.03 (1.22-3.37) 812 26 <0.001 2.42 (1.61-3.64) 
 140-159 1,144 51 <0.001 3.85 (2.31-6.41) 634 62 <0.001 3.60 (2.39-5.43) 
 160-179 447 99 <0.001 5.56 (3.32-9.31) 352 109 <0.001 5.23 (3.45-7.92) 
 ≥180 209 171 <0.001 8.57 (5.07-14.49) 183 164 <0.001 7.23 (4.71-11.11)
Abbreviation: CI, confidence interval; HR, hazard ratio; ICD-10, International Classification of Diseases, 10th revision; SBP, systolic blood 
pressure 
* Adjustment for age at entry (continuous); sex; smoking status (never, former, current smoker); alcohol intake (g/day; 0, 1-20, >20); physical 
activity (yes, no); total cholesterol (mg/dL; continuous); fasting serum glucose (mg/dL; continuous), and BMI (kg/m2; continuous). 




Age Body mass index 
Fasting glucose Total cholesterol 
Supplemental Figure 1. Sex- and age- (when applicable) adjusted hazard ratios for mortality from 
atherosclerotic vascular diseases by restricted cubic splines of continuous confounding variables with 
three knots (5th, 50th, and 95th percentiles). 
P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term with that with both the linear 
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     Years 
SBP group 0  2  4  6  8  10  12  14  16  18  
< 90 mmHg 1,862 1,836 1,818 1,788 1,754 1,721 1,673 1,636 1,596 1,332 
90-119 mmHg 412,010 410,520 408,328 405,268 401,783 397,829 393,455 388,926 384,021 343,352 
120-139 mmHg 573,091 570,817 567,302 561,526 555,061 547,655 539,669 530,997 521,704 469,910 
 ≥140 mmHg 248,283 245,762 241,580 235,714 229,139 222,137 214,818 207,285 199,510 173,605 
 
Supplemental Figure 2. Life-table survival curve for all-cause and vascular mortality by systolic blood 
pressure (SBP) group. 
Four categories of SBP (mmHg, <90, 90-109, 110-119, and ≥120) were used. The survival rate was calculated using life-table method with a time interval of one 























































Supplemental Figure 3. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
systolic blood pressure (SBP) group in all participants (graphical version of Table 2) and survivors after 5 
years of follow-up.  
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, 





















































Supplemental Figure 4. Diastolic blood pressure (DBP) and multi-variable adjusted hazard ratios for all-
cause and vascular mortality by systolic blood pressure (SBP) group in all participants (to examine 
whether the associations were independent of DBP).  
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. In Model 1, adjustment was made for age at entry, sex, smoking 
status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, body mass index, and restricted cubic splines of DBP with 
five knots (50, 60, 70, 80, 90 mmHg). In Model 2, all covariables used in Model 1 were included, while continuous confounders (age, total 






Any cause Atherosclerotic vascular diseases 
Ischemic heart diseases Total stroke 
Ischemic stroke Hemorrhagic stroke 
Supplemental Figure 5. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) 
and 90 mmHg as a reference in participants aged 60-95 years. 
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body 
mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term with the model 






















































































































Any cause (p<0.0001) Atherosclerotic vascular diseases (P<0.0001) 
Ischemic heart diseases (P=0.3496) Total stroke (P=0.0001) 
Ischemic stroke (P=0.0026) Hemorrhagic stroke (P=0.4419) 
Supplemental Figure 6. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) 
and 90 mmHg as a reference in participants aged 30-59 years. 
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body 
mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with 







































































































































































Supplemental Figure 7. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
systolic blood pressure (SBP) group according to sex.  
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, 




Any cause Atherosclerotic vascular diseases 
Ischemic heart diseases Total stroke 
Ischemic stroke Hemorrhagic stroke 
Supplemental Figure 8. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) 
and 90 mmHg as a reference in men. 
Adjustment was made for age at entry, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass 
index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both 






















































































































Any cause Atherosclerotic vascular diseases 
Ischemic heart diseases Total stroke 
Ischemic stroke Hemorrhagic stroke 
Supplemental Figure 9. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of systolic blood pressure (SBP) with five knots (80, 90, 100, 110, and 120 mmHg) 
and 90 mmHg as a reference in women. 
Adjustment was made for age at entry, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body mass 
index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with both 























































































































































Supplemental Figure 10. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
systolic blood pressure (SBP) group in all participants and in survivors as of January 1, 2003 (follow-up 
during 2003-2012) (Sensitivity analysis, cox assumption). 
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. In survivors as of January 1, 2003 (follow-up during 2003-
2012), adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and 
body mass index. In the sensitivity model among all-participants, co-variables that may cause non-proportional hazards over the follow-up 
time (violation of proportional hazard assumption) were stratified, while for several dummy variables of SBP with potential violations of 
assumption, time-dependent co-variables (which were generated using Model Statement of PROC PHREG procedure) were introduced in order 
to address non-proportionality. In the sensitivity model, analysis (PROC PHREG) stratified by age (years; <35, 35-44, 45-54, 55-64, 65-74, 75-
84, ≥85), sex, exercise, alcohol intake (g/day; 0, 1-20, >20), total cholesterol (mg/dL; <200, 200-239, ≥240), and BMI (kg/m2; <18.5, 18.5-22.9, 
23.0-24.9, ≥ 25.0), was done after adjustment for age, fasting glucose (mg/dL, continuous), smoking status, and several time-dependent dummy 






















































Supplemental Figure 11. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
systolic blood pressure (SBP) group in all study participants and in individuals with known diseases 
(excluded in the main analysis, n=49,483) combined (Sensitivity analysis, collider stratification bias). 
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, 
























Supplemental Figure 12. Multi-variable adjusted hazard ratios for all-cause and atherosclerotic vascular 
mortality by systolic blood pressure (SBP) group in individuals with known cardiovascular diseases 
(hypertension, heart diseases, or stroke; excluded in the main analysis; n=15,277) (Sensitivity analysis). 
Eight categories of SBP (reference: 90-99 mmHg) were used. The midpoint was used as a representative value for each SBP category, except 
for both ends (80 and 188), for which the average of all participants was used. Adjustment was made for age at entry, sex, smoking status, 






































































Supplemental Figure 13. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
diastolic blood pressure (DBP) group in all participants (to examine whether the associations were 
independent of SBP).  
Eight categories of DBP (mmHg; <50, 50-59, 60-69 [reference], 70-79, 80-89, 90-99, 100-109, ≥110) were used. The midpoint was used as a 
representative value for each DBP category, except for both ends (41 and 114), for which the average of all participants was used. In the Main 
model, adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and 
body mass index. In the Main model +SBP, additional adjustment was made for restricted cubic splines of systolic blood pressure (SBP) 








Any cause Atherosclerotic vascular diseases 
Ischemic heart diseases Total stroke 
Ischemic stroke Hemorrhagic stroke 
Supplemental Figure 14. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of diastolic blood pressure (DBP) with five knots (50, 60, 70, 80, and 90 mmHg) and 
60 mmHg as a reference. 
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body 
mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term with the model 
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Supplemental Figure 15. Systolic blood pressure and multi-variable adjusted hazard ratios for all-cause 
and vascular mortality by restricted cubic splines of diastolic blood pressure (DBP) with five knots (50, 60, 
70, 80, and 90 mmHg) and 60 mmHg as a reference. 
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, body mass 
index, and restricted cubic splines of systolic blood pressure with five knots (80, 90, 100, 110, and 120 mmHg). P-values for linearity were 










































































































































































Supplemental Figure 16. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by pulse 
pressure (PP) groups in all participants.  
Seven categories of PP (mmHg; <30, 30-39 [reference], 40-49, 50-59, 60-69, 70-79, ≥80) were used. The midpoint was used as a 
representative value for each PP category, except for both ends (21 and 86), for which the average of all participants was used. Adjustment was 
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Supplemental Figure 17. Multi-variable adjusted hazard ratios for all-cause and vascular mortality by 
restricted cubic splines of pulse pressure (PP) with five knots (20, 30, 40, 50, and 60 mmHg) and 40 mmHg 
as a reference.  
Adjustment was made for age at entry, sex, smoking status, alcohol intake, physical activity, total cholesterol, fasting serum glucose, and body 
mass index. P-values for linearity were calculated using the likelihood ratio test, comparing the model with only the linear term to the model with 
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